Fisher & Paykel Healthcare Corporation Limited logo

NOTIFICATION OF ISSUE OF SECURITIES

Insider Disclosure27 February 2017FPHHealthcare

Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)


NOTIFICATION OF ISSUE OF SECURITIES

Auckland, New Zealand, 28 February 2017 - Fisher & Paykel Healthcare Corporation Limited

(NZSX:FPH, ASX:FPH) advises that the following securities were issued pursuant to the

Company’s 2012 and 2013 issue of options under the Fisher & Paykel Healthcare 2003 Share

Option Plan. The issue of options and shares under the Option Plan was approved by the Board

on 22 August 2012 and 27 August 2013 respectively.

(a) Class of security Ordinary shares

ISIN NZFAPE0001S2

(b) Number issued 14,896

(c) Issue price $2.06 (12,500 shares); $3.57 (2,396 shares)

(d) Payment terms Nil refer (g) below

(e) Amount paid up In full

(f) Percentage of total class issued 0.00262%

(g) Reason for issue Employee cancelling options issued under the 2013

issue of the Fisher & Paykel Healthcare 2003 Share

Option Plan.

4,020 options were cancelled on 28 February 2017

pursuant to the Cancellation Offer approved by

shareholders at the ASM held on 12 August 2004.

2,396 shares were issued in consideration of the

cancellation of the options and are equal in value to the

gain on the options (such gain being calculated based

on an exercise price of $3.57).

12,500 shares were issued to an employee exercising

options issued under the 2012 issue of the Fisher &

Paykel Healthcare 2003 Share Option Plan based on

an exercise price of $2.06.

(h) Authority for issue Directors’ resolution

(i) Terms of issue The shares rank pari passu with the existing ordinary

shares.

(j) Total number of securities after

issue

567,484,875

(l) Date of issue 28 February 2017


This advice is given under Listing Rule 7.12.1.

Ends

Contact: Tony Barclay, Company Secretary on +64 9 574 0119. For more information about the

company visit our website www.fphcare.com

---

+ See chapt er 1 9 f or def i ned t er ms.

04/ 03/ 2013 A ppendix 3 B Page 1

Rul e 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B


New issue announcement,

application for quotation of additional securities

and agreement


I nfor mati on or documents not avai l abl e now must be gi ven to ASX as soon as avai l abl e. I nfor mati on and

documents gi ven to ASX become ASX’ s pr oper ty and may be made publ i c.

Introduced 01/ 07/ 96 O rigin: A ppendix 5 A mended 01/ 07/ 98, 01/ 09/ 99, 01/ 07/ 00, 30/09/ 01, 11/03/ 02, 01/ 01/ 03,

24/ 10/ 05, 01/ 08/ 12, 04/ 03/ 13



N ame of ent i t y

Fisher & Paykel Healthcare Corporation Limited


A BN

098 026 281



We ( t he ent i t y) gi ve A SX t he f ol l owi ng i nf or mat i on.



Part 1 - All issues

You must compl ete the r el evant secti ons (attach sheets i f ther e i s not enough space).


1

+

C l ass o f

+

sec u r i t i es i ssu ed o r t o

b e i ssu ed


Ordinary Shares



2 Number of

+

sec u r i t i es i ssu ed o r

t o be issued ( if known) or

maximum number which may be

i ssu ed


14,896


3 Principal terms of the
+

sec u r i t i es

(e.g. i f opt i ons, exer ci se pr i ce

and expiry date; if partly paid

+

securit ies, t he amount

out st anding and due dates for

payment; if

+

conver t i bl e

secur i t i es, t he conver si on pr i ce

and dates for conversion)

I ssu e o f 2,396 fully paid ordinary shares

following cancellation of 4,020 options

gr ant ed under t he Fi sher & Paykel

Healthcare Share O ption Plan in Sept ember

2013.


T he shar es wer e i ssued i n consi der at i on of

the cancellation of the options and are equal

in value to the gain on the options ( such

gai n bei ng cal cul at ed based on an exer ci se

price of $3.57).


Issue of 12,500 fully paid ord i n ar y sh ar es

following exercise of 12,500 options

gr ant ed under t he Fi sher & Paykel

Healthcare O ption Plan in A ugust 2 0 1 2

based on an exer ci se pr i ce of $ 2 . 0 6 .




4 Do t he

+

securit ies rank equally

i n al l r espect s f r om t he

+

i ssu e

d at e wi t h an exi st i ng

+

cl ass of

quot ed

+

sec u r i t i es?


If the additional

+

sec u r i t i es d o

no t r ank equal l y , p l ease st at e:

• t he dat e from which t hey do

• t he ext ent t o which t hey

participate for the next

dividend, (in the case of a

trust, distribution) or interest

payment

• the extent to which t hey do

not rank equally, ot her t han

in relat ion t o t he next

dividend, distribution or

i nt er est payment


Yes



5 Issue price or consideration


NZD3.57 (A U D3 .35) per ordinary share -

2,396 sh ar es.

NZD2.06 (AUD1.93) per ordinary share -

12,500 shar es




+ See chapt er 1 9 f or def i ned t er ms.


04/ 03/ 2013 A ppendix 3 B Page 3

6 Pu r p o se o f t h e i ssu e

(If issued as consideration for the

acquisition of assets, clearly

i d en t i f y t h o se asset s)







Issued to employees under the ‘‘Fi sh er &

Paykel H ealthcare 2003 Share Option Plan’’

- -- 14,896 sh ar es.




6a Is t he ent it y an

+

eligible entity

t hat has obt ained securit y holder

approval under rule 7.1A ?


I f Yes, compl et e sect i ons 6 b - --

6 h i n r el ati on to the

+

secur i t i es

the subj ect of thi s Appendi x 3B,

and comply with section 6 i

No



6b T he dat e t he secur i t y hol der

resolut ion under rule 7 .1 A was

p assed




6c N umber of

+

sec u r i t i es i ssu ed

without security holder approval

under rule 7 .1




6d N umber of

+

sec u r i t i es i ssu ed

with security holder approval

under rule 7 .1A




6e N umber of

+

sec u r i t i es i ssu ed

with security holder approval

under rule 7 .3 , or anot her

specific security holder approval

( speci f y dat e of meet i ng)





6f N umber of

+

sec u r i t i es i ssu ed

under an except ion in rule 7 .2




6g If

+

securities issued under rule

7 . 1 A , w as i ssu e p r i c e at l east

75% of 15 day VWAP as

calculat ed under rule 7 .1 A .3 ?

Include t he

+

issue dat e and bot h

v al u es. Include t he source of t he

V WA P calculation.



6h If
+

secur i t i es wer e i ssued under

rule 7 .1 A for non-c ash

cons

ideration, state date on

which valuat ion of considerat ion

was r el eased t o A SX M ar ket

A nnouncement s




6i Cal cul at e t he ent i t y’ s r emai ni ng

issue capacit y under rule 7 .1 and

rule 7.1A - -- compl et e A nnexur e

1 and r el ease t o A SX M ar ket

A nnouncement s




7

+

I ssu e dat es

N ot e: The i ssue dat e may be pr escr i bed by

A SX ( r ef er t o t he def i ni t i on of i ssue dat e i n

r ul e 1 9 . 1 2 ) . For exampl e, t he i ssue dat e f or a

pro rata entitlement issue must comply with

the applicable timetable in A ppendix 7A .

Cr oss r ef er ence: i t em 33 of A ppendix 3B.

28 Febr uar y 2017




N umber

+

C l ass

8 N umber and

+

class of all

+

securit ies quot ed on A SX

(i ncl udi ng t he

+

securities in

sec t i o n 2 if applicable)




567,484,875 Ordinary Shares


+ See chapt er 1 9 f or def i ned t er ms.


04/ 03/ 2013 A ppendix 3 B Page 5

Part 2 - Pro rata issue


9 Number and +class of all

+securities not quoted on

ASX (including the

securities in clause 2 if

applicable


Number Class



FPHAJ 395,160 PSRs expiring 6 September

2021, NZ$Nil exercise price.


FPHAH 459,260 PSRs expiring 8 September

2020, NZ$Nil exercise price.


FPHAF 554,170 PSRs expiring 28 August 2019,

NZ$Nil exercise price.


FPHAD 2,530 PSRs expiring 4 September

2018, NZ$Nil exercise price.


FPHAB 1,216,727 Options expiring 6 September

2021, exercise price NZ$9.82.


FPHAI 35,480 Options expiring 11 September

2020, exercise price NZ$7.23.



FPHAG 1,219,100 Options expiring 8 September

2020, exercise price NZ$7.23.



FPHAE 1,453,190 Options expiring 28 August 2019,

exercise price NZ$4.88.



FPHAC 1,541,910 Options expiring 4 September

2018, exercise price NZ$3.57.



FPHAS 1,078,150 Options expiring 30 August 2017,

exercise price NZ$2.06.



10 Dividend policy (in the case of a

t rust , dist ribut ion policy) on t he

i ncr eased capi t al ( i nt er est s)

N o change

11 Is security holder approval

r equi r ed?





12 I s t he issue renounceable or non-

renounceable?




13 Rat io in which t he

+

securities will

be of f er ed




14

+

C l ass o f

+

securit ies t o which t he

of f er r el at es





15

+

Record date to determine

ent i t l ement s




16 Will holdings on different registers

(or subr egi st er s) be aggr egat ed

for calculating entitlements?




17 Policy for deciding entitlements in

relation to fractions





18 N ames of count ries in which t he

ent it y has securit y holders who

will not be sent new offer

documents

N ot e: Secur i t y holders must be told how their

ent i t l ement s ar e t o be deal t wi t h.

Cr oss r ef er ence: r ul e 7 . 7 .




19 Closing date for receipt of

accept ances or renunciat ions


+ See chapt er 1 9 f or def i ned t er ms.


04/ 03/ 2013 A ppendix 3 B Page 7


20 N ames of any under wr i t er s






21 A mount of any underwrit ing fee

or commission




22 N am es o f an y b r o k er s t o t h e i ssu e






23 Fee or commission payable to the

broker t o t he issue




24 A mount of any handling fee

payable to brokers who lodge

accept ances or renunciat ions on

behalf of securit y holders




25 If t he issue is cont ingent on

security holders’ approval, the

dat e of t he meet i ng




26 Dat e ent i t l ement and accept ance

form and offer documents will be

sent t o per sons ent i t l ed




27 If t he ent it y has issued opt ions,

and the terms entitle option

holders to participate on exer ci se,

t he dat e on which not ices will be

sent to option holders




28 Date rights trading will begin (if

applicable)




29 Date rights trading will end (if

applicable)






30 How do security holders sell their

ent i t l ement s i n ful l t hrough a

broker ?




31 How do security holders sell par t

of t heir ent it lement s t hrough a

broker and accept for the

bal ance?




+ See chapt er 1 9 f or def i ned t er ms.


A ppendi x 3 B Page 8 04/ 03/ 2013


32 How do security holders dispose

of t hei r ent i t l ement s ( except by

sale t hrough a broker) ?




33

+

I ssu e d at e






Part 3 - Quotation of securities

You need onl y compl ete thi s secti on i f you ar e appl yi ng for quotati on of secur i ti es


34 Type of

+

secur i t i es

(ti ck one)


( a)


+

Secur i t i es descr i bed i n Par t 1



( b)


A ll other

+

secur i t i es

Exampl e: r estricted securities at the end of the escrowed period, partly paid securities that become fully paid,

empl oyee i ncent i ve shar e secur i t i es when r est r i ct i on ends, secur i t i es i ssued on expi r y or conver si on of conver t i bl e

secur i t i es


Entities that have ticked box 34(a)


Additional securities forming a new class of securities



Ti ck to i ndi cate you ar e pr ovi di ng the i nfor mati on or

documents



35


If the

+

secur i t i es ar e

+

equi t y secur i t i es, t he names of t he 2 0 l ar gest hol der s of t he

additional

+

securit ies, and t he number and percent age of addit ional

+

sec u r i t i es

held by t hose holders



36


If the

+

secur i t i es ar e

+

equit y securit ies, a dist ribut ion schedule of t he addit ional

+

securit ies set t ing out t he number of holders in t he cat egor i es

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over



37


A copy of any trust deed for the additional

+

secur i t i es


+ See chapt er 1 9 f or def i ned t er ms.


04/ 03/ 2013 A ppendix 3 B Page 9


Entities that have ticked box 34(b)


38 N umber of

+

securit ies for which

+

quot at ion is sought






39

+

C l ass o f

+

securit ies for which

quot at ion is sought





40 Do t he

+

securit ies rank equally in

al l r espect s f r om t he

+

i ssu e d at e

wit h an exist ing

+

class of quoted

+

sec u r i t i es?


If the additional

+

securities do not

r ank equal l y , p l ease st ate:

• t he dat e from which t hey do

• t he ext ent t o which t hey

participate for the next

dividend, (in the case of a

trust, distribution) or interest

payment

• t he ext ent t o which t hey do

not rank equally, ot her t han in

relation to the next dividend,

dist ribut ion or i nt er est

payment




41 Reason for request for quot at ion

now

Exampl e: I n t he case of r est r i ct ed secur i t i es, end

of restriction period


(if issued upon conversion of

anot her

+

security, clearly identify

that other

+

sec u r i t y )






N umber

+

C l ass

42 Number and

+

class of all

+

securit ies quot ed on A SX

(i ncl udi ng t he

+

securities in clause

38)







+ See chapt er 1 9 f or def i ned t er ms.


A ppendi x 3 B Page 10 04/ 03/ 2013



Quot at i on agr eement


1

+

Q uotation of our additional

+

securities is in A SX’s absolute discretion. A SX

may quote the

+

securities on any conditions it decides.


2 We war r ant t he f ol l owi ng t o A SX .


• T he i ssue of t he

+

securities to be quoted complies with the law and is

not for an illegal purpose.


• There is no reason why those

+

securities should not be granted

+

quotation.


• A n offer of the

+

sec u r i t i es f o r sale within 1 2 months after their issue

will not require disclosure under section 7 0 7 ( 3 ) or section 1012C(6)

of the Corporations A ct.

N ote: A n entity may need to obtain appropriate warranties from subscribers for the securities in order to be able

t o gi ve t hi s war r ant y


• Section 724 or section 1016E of the Corporations A ct does not apply

to any applications received by us in relation to any

+

secur i t i es t o be

quoted and that no-one has any right to return any

+

secur i t i es t o be

quoted under sections 7 3 7 , 7 38 or 1016F of the Corporations A ct at

the time that we request that the

+

secur i t i es be quot ed.


• If we are a trust, we warrant that no person has the right to return the

+

securities to be quoted under section 1019B of the Corporations A ct

at the time that we r equest t hat t he

+

secur i t i es be quot ed.


3 We wi l l i ndemni f y A SX t o t he f ul l est ext ent per mi t t ed by l aw i n r espect of any

claim, action or expense arising from or connected with any breach of the

war r ant i es i n t hi s agr eement .


4 We gi ve A SX t he i nf or mation and documents required by this form. If any

information or document i s no t avai l abl e no w, we will give it to A SX before

+

quotation of the

+

secur i t i es begi ns. We acknowl edge t hat A SX i s r el yi ng on

the information and documents. We warrant that they ar e ( wi l l be) t r ue and

compl et e.



Si gn her e: ................................................ Dat e: 28 Febr uar y 2017

Company Secr et ar y


Print name: A nt o ny G . Bar cl ay


== == == == ==

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.